156 related articles for article (PubMed ID: 8554940)
1. Detection of autoantibodies directed against human hepatic endoplasmic reticulum in sera from patients with halothane-associated hepatitis.
Kitteringham NR; Kenna JG; Park BK
Br J Clin Pharmacol; 1995 Oct; 40(4):379-86. PubMed ID: 8554940
[TBL] [Abstract][Full Text] [Related]
2. Sera from patients with halothane hepatitis contain antibodies to halothane-induced liver antigens which are not detectable by immunoblotting.
Knight TL; Scatchard KM; Van Pelt FN; Kenna JG
J Pharmacol Exp Ther; 1994 Sep; 270(3):1325-33. PubMed ID: 7932186
[TBL] [Abstract][Full Text] [Related]
3. Absence of anti-trifluoroacetate antibody after halothane anaesthesia in patients exhibiting no or mild liver damage.
Sakaguchi Y; Inaba S; Irita K; Sakai H; Nawata H; Takahashi S
Can J Anaesth; 1994 May; 41(5 Pt 1):398-403. PubMed ID: 8055607
[TBL] [Abstract][Full Text] [Related]
4. Human anti-endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesterase.
Satoh H; Martin BM; Schulick AH; Christ DD; Kenna JG; Pohl LR
Proc Natl Acad Sci U S A; 1989 Jan; 86(1):322-6. PubMed ID: 2911577
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis.
Eliasson E; Kenna JG
Mol Pharmacol; 1996 Sep; 50(3):573-82. PubMed ID: 8794896
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies associated with volatile anesthetic hepatitis found in the sera of a large cohort of pediatric anesthesiologists.
Njoku DB; Greenberg RS; Bourdi M; Borkowf CB; Dake EM; Martin JL; Pohl LR
Anesth Analg; 2002 Feb; 94(2):243-9, table of contents. PubMed ID: 11812677
[TBL] [Abstract][Full Text] [Related]
7. Detection of antibodies to a halothane metabolite hapten in sera from patients with halothane-associated hepatitis.
Bird GL; Williams R
J Hepatol; 1989 Nov; 9(3):366-73. PubMed ID: 2607125
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to hepatic microsomal carboxylesterase in halothane hepatitis.
Smith GC; Kenna JG; Harrison DJ; Tew D; Wolf CR
Lancet; 1993 Oct; 342(8877):963-4. PubMed ID: 8105217
[TBL] [Abstract][Full Text] [Related]
9. Human hepatocytes express trifluoroacetylated neoantigens after in vitro exposure to halothane.
Ilyin GP; Rissel M; Malledant Y; Tanguy M; Guillouzo A
Biochem Pharmacol; 1994 Aug; 48(3):561-7. PubMed ID: 8068043
[TBL] [Abstract][Full Text] [Related]
10. Processing of endoplasmic reticulum luminal antigens associated with halothane hepatitis in rat hepatocytes.
Amouzadeh HR; Pohl LR
Hepatology; 1995 Sep; 22(3):936-43. PubMed ID: 7657302
[TBL] [Abstract][Full Text] [Related]
11. Metabolic basis for a drug hypersensitivity: antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane.
Kenna JG; Satoh H; Christ DD; Pohl LR
J Pharmacol Exp Ther; 1988 Jun; 245(3):1103-9. PubMed ID: 3385639
[TBL] [Abstract][Full Text] [Related]
12. Screening for antibodies associated with halothane hepatitis.
Hastings KL; Thomas C; Hubbard AK; Gandolfi AJ
Br J Anaesth; 1991 Dec; 67(6):722-8. PubMed ID: 1768541
[TBL] [Abstract][Full Text] [Related]
13. Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis.
Bourdi M; Chen W; Peter RM; Martin JL; Buters JT; Nelson SD; Pohl LR
Chem Res Toxicol; 1996; 9(7):1159-66. PubMed ID: 8902272
[TBL] [Abstract][Full Text] [Related]
14. Identification by immunoblotting of three halothane-induced liver microsomal polypeptide antigens recognized by antibodies in sera from patients with halothane-associated hepatitis.
Kenna JG; Neuberger J; Williams R
J Pharmacol Exp Ther; 1987 Aug; 242(2):733-40. PubMed ID: 3302210
[TBL] [Abstract][Full Text] [Related]
15. Association of anti-58 kDa endoplasmic reticulum antibodies with halothane hepatitis.
Martin JL; Reed GF; Pohl LR
Biochem Pharmacol; 1993 Oct; 46(7):1247-50. PubMed ID: 8216376
[TBL] [Abstract][Full Text] [Related]
16. Evidence for expression in human liver of halothane-induced neoantigens recognized by antibodies in sera from patients with halothane hepatitis.
Kenna JG; Neuberger J; Williams R
Hepatology; 1988; 8(6):1635-41. PubMed ID: 3192177
[TBL] [Abstract][Full Text] [Related]
17. Halothane metabolism: immunochemical evidence for molecular mimicry of trifluoroacetylated liver protein adducts by constitutive polypeptides.
Christen U; Bürgin M; Gut J
Mol Pharmacol; 1991 Sep; 40(3):390-400. PubMed ID: 1716732
[TBL] [Abstract][Full Text] [Related]
18. Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis.
Bourdi M; Larrey D; Nataf J; Bernuau J; Pessayre D; Iwasaki M; Guengerich FP; Beaune PH
J Clin Invest; 1990 Jun; 85(6):1967-73. PubMed ID: 2347920
[TBL] [Abstract][Full Text] [Related]
19. Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug.
Beaune P; Dansette PM; Mansuy D; Kiffel L; Finck M; Amar C; Leroux JP; Homberg JC
Proc Natl Acad Sci U S A; 1987 Jan; 84(2):551-5. PubMed ID: 3540968
[TBL] [Abstract][Full Text] [Related]
20. The lipoic acid containing components of the 2-oxoacid dehydrogenase complexes mimic trifluoroacetylated proteins and are autoantigens associated with halothane hepatitis.
Frey N; Christen U; Jenö P; Yeaman SJ; Shimomura Y; Kenna JG; Gandolfi AJ; Ranek L; Gut J
Chem Res Toxicol; 1995; 8(5):736-46. PubMed ID: 7548757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
